Dr Paul Kooner, Consultant Hepatologist
Dr Paul Kooner
Consultant Hepatologist
Dr Paul Kooner FRCP MBBS BSc
Consultant Hepatologist
Dr Paul Kooner
Consultant Hepatologist FRCP MBBS BSc
Areas of expertise
- Fatty liver disease
- MASLD / NAFLD
- Abnormal liver blood tests / abnormal liver imaging
- FibroScan
- Alcohol related liver problems
Recommendations for Dr Kooner
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
London Digestive Centre
41 Welbeck Street, London, W1G 8DU
-
The Princess Grace Hospital
42-52 Nottingham Place, London, W1U 5NY
Queen's Hospital (NHS)
Rom Valley Way, Romford, Essex, RM7 0AG
Barking Hospital (NHS)
Upney Lane, Barking, Essex, IG11 9LX
Barts Health NHS Trust
Newham University Hospital, Glen Rd, London, E13 8SL
About Dr Paul Kooner
GMC number: 4333069
Year qualified: 1996
Place of primary qualification: University of London
Initial consultation fee: £250
Follow up consultation fee: £175
Dr Paul Kooner is a Consultant Hepatologist, qualified from the University of London. He has been trained in major London liver units such as the Royal Free Hospital and King's College Hospital. Dr Paul Kooner is an experienced Consultant Hepatologist with an interest in all aspects of liver disease, as well as general gastroenterology.
He looks after patients with chronic liver diseases including fatty liver disease, cirrhosis, viral hepatitis (hepatitis B and hepatitis C) and autoimmune liver disease. His areas of clinical expertise include chronic liver diseases, fatty liver diseasecirrhosis, viral hepatitis, autoimmune liver disease, abnormal liver blood tests, hepatocellular carcinoma, liver transplantation, decompensated cirrhosis and endoscopy.
Dr Paul Kooner also has an experience of managing decompensated cirrhosis and liver transplantation. In the field of endoscopy, his main interest is portal hypertension. He is a member of European Association of the Study of the Liver and fellow of the Royal College of Physicians.
Areas of expertise
- Abnormal liver blood tests/abnormal liver imaging
- Alcohol dependence
- Alcohol related liver problems
- Alcohol-related liver disease
- Autoimmune hepatitis
- Bile duct diseases
- Cirrhosis
- Fatty liver disease
- FibroScan
- Hepatocellular carcinoma
- Liver cancer
- Liver disease
- Liver function tests
- Liver screening (risk stratification)
- MASLD/NAFLD
Frequently asked questions
Why did you decide to become a Consultant Hepatologist ?
Liver disease is uniquely challenging because it often causes no symptoms until it is very advanced. By that stage, opportunities to intervene may have been missed. I am passionate about identifying liver disease early, sometimes when there are very few signals, and helping patients understand and reduce their risk factors. Around 90% of early liver disease is reversible with lifestyle modification, so early diagnosis and patient engagement are key.
What are the common symptoms that your patients tend to present with?
Most patients have no symptoms at all. They are often referred because of abnormal liver blood tests or an incidental finding on ultrasound, CT or MRI. Occasionally, patients may experience pain related to biliary obstruction. In advanced cases, symptoms can include jaundice, fluid retention in the abdomen or legs, or general weakness. My aim is to identify disease long before these complications develop.
What are the treatments that you're able to offer your patients?
I begin with a detailed clinical assessment, blood tests and liver imaging. A key investigation is the liver FibroScan, which allows us to assess liver scarring accurately. Treatment depends on the underlying cause. For many patients with metabolic-related fatty liver disease, lifestyle modification is central, including optimisation of weight, blood pressure, cholesterol and diabetes. New pharmacological therapies are emerging, particularly for metabolic liver disease. For autoimmune conditions, immunosuppressive treatments may be required. For alcohol-related disease, structured counselling and fibrosis monitoring are essential.
What are your areas of sub-specialist interest?
My current focus is early liver disease detection and risk assessment. I am particularly interested in metabolic liver disease and early fatty liver disease. I also have a long-standing interest in hepatocellular carcinoma and the management of alcohol-related liver disease. Early intervention and patient engagement are central to my practice.
Professional memberships


